BIMI vs. COSM, MEDS, COEP, KPRX, CHEK, CHRO, ERNA, PPBT, IMNN, and OTRK
Should you be buying BIMI stock or one of its competitors? The main competitors of BIMI include Cosmos Health (COSM), TRxADE HEALTH (MEDS), Coeptis Therapeutics (COEP), Kiora Pharmaceuticals (KPRX), Check-Cap (CHEK), Chromocell Therapeutics (CHRO), Eterna Therapeutics (ERNA), Purple Biotech (PPBT), Imunon (IMNN), and Ontrak (OTRK). These companies are all part of the "medical" sector.
Cosmos Health (NASDAQ:COSM) and BIMI (NASDAQ:BIMI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, community ranking, institutional ownership, earnings, media sentiment and analyst recommendations.
Cosmos Health has higher revenue and earnings than BIMI.
In the previous week, Cosmos Health had 2 more articles in the media than BIMI. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for BIMI. Cosmos Health's average media sentiment score of 0.30 beat BIMI's score of 0.24 indicating that BIMI is being referred to more favorably in the news media.
12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 0.1% of BIMI shares are owned by institutional investors. 18.7% of Cosmos Health shares are owned by company insiders. Comparatively, 69.0% of BIMI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
BIMI received 5 more outperform votes than Cosmos Health when rated by MarketBeat users. However, 70.69% of users gave Cosmos Health an outperform vote while only 57.50% of users gave BIMI an outperform vote.
Cosmos Health has a beta of 5.84, meaning that its share price is 484% more volatile than the S&P 500. Comparatively, BIMI has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500.
Cosmos Health has a net margin of -31.48% compared to Cosmos Health's net margin of -94.58%. BIMI's return on equity of -28.54% beat Cosmos Health's return on equity.
Summary
Cosmos Health beats BIMI on 10 of the 14 factors compared between the two stocks.
Get BIMI News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIMI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BIMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
